Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons

Biochem Biophys Res Commun. 2017 Jan 29;483(1):88-93. doi: 10.1016/j.bbrc.2016.12.188. Epub 2017 Jan 3.

Abstract

Patient-specific induced pluripotent stem cells (iPSCs) show promise for use as tools for in vitro modeling of Parkinson's disease. We sought to improve the efficiency of dopaminergic (DA) neuron induction from iPSCs by the using surface markers expressed in DA progenitors to increase the significance of the phenotypic analysis. By sorting for a CD184high/CD44- fraction during neural differentiation, we obtained a population of cells that were enriched in DA neuron precursor cells and achieved higher differentiation efficiencies than those obtained through the same protocol without sorting. This high efficiency method of DA neuronal induction enabled reliable detection of reactive oxygen species (ROS) accumulation and vulnerable phenotypes in PARK2 iPSCs-derived DA neurons. We additionally established a quantitative system using the mt-mKeima reporter system to monitor mitophagy in which mitochondria fuse with lysosomes and, by combining this system with the method of DA neuronal induction described above, determined that mitophagy is impaired in PARK2 neurons. These findings suggest that the efficiency of DA neuron induction is important for the precise detection of cellular phenotypes in modeling Parkinson's disease.

Keywords: Dopaminergic neurons; Flow cytometry; Induced pluripotent stem cells; Mitophagy; Parkinson's disease.

MeSH terms

  • Apoptosis
  • Cell Differentiation / physiology
  • Cell Line
  • Dopaminergic Neurons / cytology*
  • Dopaminergic Neurons / metabolism*
  • Humans
  • Hyaluronan Receptors / metabolism
  • Induced Pluripotent Stem Cells / cytology*
  • Induced Pluripotent Stem Cells / metabolism*
  • Mitophagy / physiology
  • Models, Neurological
  • Neural Stem Cells / cytology
  • Neural Stem Cells / metabolism
  • Parkinson Disease / etiology
  • Parkinson Disease / metabolism
  • Parkinson Disease / pathology
  • Reactive Oxygen Species / metabolism
  • Ubiquitin-Protein Ligases / metabolism*

Substances

  • CD44 protein, human
  • Hyaluronan Receptors
  • Reactive Oxygen Species
  • Ubiquitin-Protein Ligases
  • parkin protein